Cell Biology
Researchers' work from the United Kingdom, Austria and Germany adds to cell biology body of knowledge
Published in Blood Weekly, August 10th, 2006
Study 1: Valganciclovir is safe and effective as pre-emptive therapy for cytomegalovirus infection in allogeneic stem cell transplantation.
"Despite significant advances in prevention and therapy, cytomegalovirus (CMV) infection continues to be an important cause of morbidity and mortality in the hematopoietic stem cell transplant (HSCT) recipient. The standard drug for pre-emptive therapy is intravenous ganciclovir (GCV)," scientists in the United States report.
According to researchers, "Valganciclovir (VGC), the oral prodrug of GCV,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2006-08-10)
More Articles from Blood Weekly
- Blood Vessel Tissue Engineering
Artificial blood vessel was fabricated - Colorectal Cancer
Fetal hemoglobin-blood cells developed within colorectal tumor tissues - HIV/AIDS Blood Banking
Illegal blood banks continue to operate in China - Tissue Engineering
Bone implant pretreatment with cyclic RGD-peptides enhances osteointegration - Tissue Engineering
Microchannel reactor for tissue engineering mathematically modeled - Anemia
Colorectal cancer and anemia interact to increase angiogenesis and cancer proliferation markers - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
